Laboratory Equipment & Diagnostics

Molecular Designs wins FDA clearance for FluA/FluB/RSV panel

Image
Molecular Designs wins FDA clearance for FluA/FluB/RSV panel

BIRMINGHAM -- November 16, 2026 -- Molecular Designs has received U.S. FDA 510(k) clearance (K262789) for its SimplicityDx Panel FluA/FluB/RSV, the first FDA-cleared assay from the Alabama-based company, it announced on Nov. 13, 2026. The multiplex real-time RT-PCR test detects and differentiates influenza A, influenza B and respiratory syncytial virus (RSV) RNA in anterior nasal swab specimens in a single run, with an internal control as a fourth target.

Clearance limits the panel to CLIA high-complexity laboratories

The panel is for prescription use only. It is cleared for laboratories certified under CLIA to perform high-complexity tests, so labs without that certification fall outside the cleared use.

The specimens come from individuals with signs and symptoms of respiratory tract infection. Results are intended as an aid in differential diagnosis, alongside clinical, epidemiologic and laboratory findings.

Dana-Farber adds n6 icon96 to cfDNA service, cutting yield CV to 8%

Image
Dana-Farber adds n6 icon96 to cfDNA service, cutting yield CV to 8%

PLEASANTON — November 13, 2026 -- The Molecular Biology Core Facilities (MBCF) at Dana-Farber Cancer Institute have added n6 Tec's icon96 system to their targeted cell-free DNA (cfDNA) sequencing service. MBCF reports that the coefficient of variation (CV) in library yield across 10 ng samples fell from 54% with fixed-cycle amplification to 8% with n6's AutoNorm software.

That is a drop of 46 percentage points, or about 85% by our calculation. The figures come from an n6 application note and a SelectScience webinar in which MBCF reported its results. They are not independently published data.

Lab consumables market to reach USD 25.5 billion by 2031, firm says

Image
Lab consumables market to reach USD 25.5 billion by 2031, firm says

DELRAY BEACH -- November 13, 2026 -- MarketsandMarkets projects that the global lab consumables market will grow from USD 17.3 billion in 2026 to USD 25.5 billion by 2031, a compound annual growth rate of 8.0%. The USD 8.2 billion increase equals about 47% of the 2026 base, by our calculation, or roughly USD 1.6 billion of added annual sales on average over the five years.

Microplates, diagnostic centers and clinical diagnostics are forecast to outgrow the market

The research firm expects three segments to grow faster than the 8.0% market rate. Microplates are forecast at 9.5% a year, 1.5 percentage points above the market. Diagnostic centers as end users are forecast at 9.0%, and clinical diagnostics as an application at 8.5%.

RM Analytical adds cGMP testing for six sunscreen UV filters

Image
RM Analytical adds cGMP testing for six sunscreen UV filters

CLIFTON -- November 12, 2026 -- CS Analytical, trading as Raw Material Analytical (RM Analytical), is set to offer cGMP analytical testing for six sunscreen ingredients: avobenzone, homosalate, octisalate, octocrylene, octinoxate and oxybenzone. The New Jersey laboratory says the service will cover both over-the-counter sunscreen drug products and cosmetic and personal care formulations.

All six are organic UV filters that protect across UVA and UVB wavelengths. Manufacturers, formulators and suppliers can use the testing to verify the identity, purity and potency of these raw materials before production. The company says this reduces the risk of batch failures and recalls.

CEO Brian Mulhall says adding the six ingredients helps clients confirm that their materials meet the standards their customers and regulators expect.